Skip to content
Descubridor Institucional UMAR
Inicio
Búsqueda avanzada
Explorar
Inicio
Búsqueda avanzada
Explorar
Login
Language
English
Deutsch
Español
Français
Italiano
All Fields
Title
Author
Subject
Call Number
ISBN/ISSN
Tag
Find
Advanced
NY‐ESO‐1 antigen: A promising frontier in cancer immunotherapy
NY‐ESO‐1 antigen: A promising frontier in cancer immunotherapy
Fuente:
Wiley Open Access
Saved in:
Bibliographic Details
Main Authors:
Alaa Alsalloum
,
Julia A. Shevchenko
,
Sergey Sennikov
Format:
Artículo Open Access
Published:
Wiley
2024
Subjects:
Clinical and Translational Medicine
Online Access:
Acceder al recurso
Tags:
Add Tag
No Tags, Be the first to tag this record!
Cite this
Text this
Email this
Print
Export Record
Export to RefWorks
Export to EndNoteWeb
Export to EndNote
Save to List
Permanent link
Holdings
Description
Comments
Similar Items
Staff View
Be the first to leave a comment!
Your Comment
You must be logged in first
Similar Items
The absence of IL17A favours cytotoxic cell function and improves antigen‐specific immunotherapies in pancreatic adenocarcinoma
by: Giorgia Tiberi, et al.
Published: (2025)
Combining TIGIT blockade with IL‐15 stimulation is a promising immunotherapy strategy for lung adenocarcinoma
by: Baohong Luo, et al.
Published: (2024)
Targeting one‐carbon metabolism for cancer immunotherapy
by: Xinxin Ren, et al.
Published: (2024)
Modulating commensal bacteria to intervene in cancer immunotherapy
by: Dingjiacheng Jia, et al.
Published: (2024)
SAA1 and metabolomic signatures predict hyperprogression with immunotherapy in pan cancers
by: Xiaoqing Wang, et al.
Published: (2024)
